Abstract
Novel tetracyclic allopsoralen derivatives characterized by the condensation of a fourth cyclohexenylic (5-7) or benzenic (8-10) ring at the furan side and a methoxy (5 and 8), a hydroxy (6 and 9), or a dimethylaminopropoxy (7 and 10) side chain in the 10 position of the chromophore were prepared. Compounds 7 and 10 showed a strong photoantiproliferative activity, up to 3 orders of magnitude higher than that of the photochemotherapeutic drug 8-methoxypsoralen (8-MOP). The investigation into the mechanism of action demonstrated for 10 the capacity to intercalate between DNA base pairs in the ground state, to give rise to a covalent photoaddition upon UVA irradiation, and to inhibit polymerase chain reaction (PCR) in a sequence-specific manner. Conversely, compound 7 showed a limited capacity to form an intercalative complex and the lack of ability to photoadd to the macromolecule, thus revealing a novel and unusual behavior for an allopsoralen derivative.
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / toxicity
-
Cell Line, Tumor
-
DNA Adducts / chemical synthesis
-
DNA Topoisomerases, Type II / chemistry
-
Darkness
-
Drug Screening Assays, Antitumor
-
Furans / chemical synthesis*
-
Furans / pharmacology
-
Furans / toxicity
-
Furocoumarins / chemical synthesis*
-
Furocoumarins / pharmacology
-
Furocoumarins / toxicity
-
Guinea Pigs
-
Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
-
Heterocyclic Compounds, 4 or More Rings / pharmacology
-
Heterocyclic Compounds, 4 or More Rings / toxicity
-
Humans
-
Intercalating Agents / chemical synthesis*
-
Intercalating Agents / pharmacology
-
Intercalating Agents / toxicity
-
PUVA Therapy
-
Polymerase Chain Reaction
-
Skin / drug effects
-
Structure-Activity Relationship
-
Thymine / chemistry
-
Toxicity Tests
-
Ultraviolet Rays
Substances
-
Antineoplastic Agents
-
DNA Adducts
-
Furans
-
Furocoumarins
-
Heterocyclic Compounds, 4 or More Rings
-
Intercalating Agents
-
DNA Topoisomerases, Type II
-
Thymine